Technical Analysis for TRLS - TRLSTrellus Health plc
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Stochastic Buy Signal | Bullish | -8.73% | |
Calm After Storm | Range Contraction | -8.73% | |
Lower Bollinger Band Walk | Weakness | -8.73% | |
Inside Day | Range Contraction | -8.73% | |
Wide Bands | Range Expansion | -8.73% | |
Oversold Stochastic | Weakness | -8.73% | |
Lower Bollinger Band Walk | Weakness | -8.73% | |
Wide Bands | Range Expansion | -8.73% | |
Gapped Down | Weakness | -8.73% | |
Lower Bollinger Band Touch | Weakness | -8.73% |
Alert | Time |
---|---|
Rose Above Previous Day's High | about 2 hours ago |
Up 3% | about 2 hours ago |
Up 2% | about 2 hours ago |
Up 1% | about 2 hours ago |
Down 5% | about 4 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers TrellusElevate, a proprietary HIPAA-compliant technology platform to coordinate and deliver personalized care remotely through telemedicine. Its platform provides patients with access to a care team, educational content resources, and remote monitoring capabilities for the treatment of inflammatory bowel diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The company was founded in 2020 and is headquartered in White Plains, New York.
Sector: Healthcare
Industry: Health Information Services
Keywords: Medicine Medical Specialties Clinical Medicine Autoimmune Diseases Ulcerative Colitis Crohn's Disease Inflammatory Bowel Disease Assistive Technology Inflammatory Bowel Diseases Treatment Of Inflammatory Bowel Diseases
Classification
Sector: Healthcare
Industry: Health Information Services
Keywords: Medicine Medical Specialties Clinical Medicine Autoimmune Diseases Ulcerative Colitis Crohn's Disease Inflammatory Bowel Disease Assistive Technology Inflammatory Bowel Diseases Treatment Of Inflammatory Bowel Diseases
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 9.65 |
52 Week Low | 2.5 |
Average Volume | 86,799 |
200-Day Moving Average | 5.20 |
50-Day Moving Average | 4.13 |
20-Day Moving Average | 3.30 |
10-Day Moving Average | 3.00 |
Average True Range | 0.39 |
RSI (14) | 11.50 |
ADX | 13.86 |
+DI | 12.85 |
-DI | 15.17 |
Chandelier Exit (Long, 3 ATRs) | 3.20 |
Chandelier Exit (Short, 3 ATRs) | 3.67 |
Upper Bollinger Bands | 4.12 |
Lower Bollinger Band | 2.48 |
Percent B (%b) | 0.16 |
BandWidth | 49.42 |
MACD Line | -0.38 |
MACD Signal Line | -0.35 |
MACD Histogram | -0.0323 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.11 | ||||
Resistance 3 (R3) | 3.07 | 2.91 | 3.05 | ||
Resistance 2 (R2) | 2.91 | 2.82 | 2.93 | 3.03 | |
Resistance 1 (R1) | 2.83 | 2.76 | 2.87 | 2.87 | 3.01 |
Pivot Point | 2.67 | 2.67 | 2.69 | 2.69 | 2.67 |
Support 1 (S1) | 2.59 | 2.58 | 2.63 | 2.63 | 2.49 |
Support 2 (S2) | 2.43 | 2.52 | 2.45 | 2.47 | |
Support 3 (S3) | 2.35 | 2.43 | 2.45 | ||
Support 4 (S4) | 2.39 |